CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Oxy-helium treatment for refractory neurological decompression sickness: a case report.

A 49-yr-old male presented with paraparesis and urinary incontinence that appeared 10 min after surfacing from a dive. Treatment was started on an extended USN table 6, but the symptoms persisted. Twenty-four hours later, he was treated with oxy-helium table CX-30, resulting in marked improvement in gait and in sensory and motor function. Urodynamic examination indicated an upper motor neuron lesion; bilateral decreased amplitude of the somatosensory evoked potential was found on stimulation of the tibial nerves; no response below the upper limbs was elicited on central motor conduction time (CMCT) testing; MRI showed lesions in the lower dorsal cord. The patient's condition was further improved by an additional 10 hyperbaric oxygenation sessions, with complete restoration of urinary control and virtually complete sensory and motor recovery. Follow-up urodynamic studies were normal. CMCT recordings showed a bilateral lower limb small-amplitude response. The present case reinforces the limited clinical data regarding the value of oxy-helium in the treatment of neurological decompression sickness, even when primary treatment with oxygen tables is unsuccessful.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app